| Literature DB >> 32154007 |
Vivian Wing-Yi Li1, Anthony Pak-Yin Liu1, Karin Kar-Huen Ho2, Jeffrey Ping-Wa Yau3, Daniel Ka-Leung Cheuk1, Yiu-Fai Cheung1.
Abstract
BACKGROUND: Emerging evidence suggests potential arterial damage with the use of anthracycline-based chemotherapeutic regimens. We determined arterial function at rest and during exercise in anthracycline-treated adult survivors of childhood cancers.Entities:
Year: 2018 PMID: 32154007 PMCID: PMC7048035 DOI: 10.1186/s40959-018-0035-0
Source DB: PubMed Journal: Cardiooncology ISSN: 2057-3804
Demographic, clinical, and vascular parameters
| Survivors ( | Controls ( |
| |
|---|---|---|---|
|
| |||
| Age (years) | 25.0 ± 5.9 | 23.6 ± 5.8 | 0.16 |
| Sex (M/F) | 54/42 | 30/30 | 0.45 |
| Weight (kg) | 59.1 ± 10.8 | 59.2 ± 11.0 | 0.97 |
| Height (cm) | 166.1 ± 8.7 | 165.9 ± 8.6 | 0.85 |
| Body mass index (kg/m2) | 21.4 ± 3.2 | 21.4 ± 2.6 | 0.99 |
|
| |||
| Age at diagnosis (years) | 8.0 ± 4.8 | ||
| Duration since completion of therapy (years) | 15.4 ± 5.9 | ||
| Cumulative anthracycline dose (mg/m2) | 258 ± 110 (range, 75–675) | ||
| Diagnosis | |||
| Acute lymphoblastic leukaemia | 50 | ||
| Non-Hodgkin lymphoma | 15 | ||
| Acute myeloid leukaemia | 10 | ||
| Osteosarcoma | 4 | ||
| Hodgkin lymphoma | 5 | ||
| Wilm’s tumour | 6 | ||
| Ewing Sarcoma | 2 | ||
| Clear cell sarcoma of kidney | 1 | ||
| Ganglioneuroblastoma | 1 | ||
| Neuroblastoma | 1 | ||
| Peripheral primitive neuroectodermal tumour | 1 | ||
| Need for cardiac irradiation | 5 | ||
| Relapse | 9 | ||
| Cardiac medication | 0 | ||
|
| |||
| | |||
| IMT (mm) | 0.44 ± 0.03 | 0.41 ± 0.02 | < 0.001 |
| Stiffness index | 4.05 ± 0.02 | 3.85 ± 0.61 | < 0.001 |
| | |||
| Pulse pressure (mmHg) | 42 ± 8 | 43 ± 9 | 0.34 |
| cSBP (mmHg) | 111 ± 16 | 105 ± 16 | 0.037 |
| rAI (%) | 64 ± 15 | 57 ± 13 | 0.004 |
| rAI at 75 beats/min (%) | 64 ± 14 | 58 ± 12 | 0.009 |
cSBP central systolic blood pressure, IMT intima-media thickness, rAI radial augmentation index
Fig. 1Scatter plots showing carotid intima-media thickness (IMT) in survivors and controls. The dash line represents the cutoff of 2 standard deviations above the mean IMT of controls
Univariate and multivariate analyses of carotid intima-media thickness
| Carotid IMT | ||||
|---|---|---|---|---|
| r | p | β | p | |
| Age at study | 0.37 | < 0.001 | 0.29 | 0.005 |
| At rest | ||||
| SBP (mmHg) | −0.08 | 0.31 | −0.03 | 0.77 |
| DBP (mmHg) | 0.11 | 0.18 | 0.08 | 0.42 |
| cSBP (mmHg) | 0.13 | 0.10 | −0.04 | 0.66 |
| rAI (%) | 0.41 | < 0.001 | 0.27 | 0.006 |
| rAI at 75 beats/min (%) | 0.38 | < 0.001 | −0.01 | 0.99 |
| Carotid stiffness index | 0.02 | 0.78 | −0.07 | 0.44 |
All of the parameters were entered into the multivariate analysis. The correlation coefficient r for univariate analysis and β coefficient for multivariate analysis are presented
Abbreviations as in Table 1. DBP diastolic blood pressure, SBP systolic blood pressure
Fig. 2Scatter plot showing relationships between carotid intima-media thickness and age in survivors (solid circles) and controls (empty circles). The solid and dashed black lines represent the slope of change in carotid intima-media thickness with age in survivors and controls, respectively
Carotid stiffness index and systemic blood pressure at rest and during submaximal exercise
| Rest | Exercise | p Value | |||||
|---|---|---|---|---|---|---|---|
| Patients ( | Controls ( | Patients ( | Controls ( |
|
|
| |
| Carotid stiffness index | 4.05 ± 0.67 | 3.85 ± 0.61 | 5.59 ± 1.31 | 4.13 ± 0.62 | < 0.001 | < 0.001 | < 0.001 |
| SBP (mmHg) | 119 ± 12 | 119 ± 12 | 155 ± 17 | 153 ± 16 | 0.52 | < 0.001 | 0.77 |
| DBP (mmHg) | 72 ± 8 | 71 ± 8 | 80 ± 12 | 77 ± 9 | 0.09 | < 0.001 | 0.40 |
Abbreviations as in Table 1 and Table 2
Fig. 3Stiffness index at baseline and during submaximal exercise in survivors and controls. The dashed lines represent the cutoff of 2 standard deviations above the mean stiffness index at submaximal exercise of controls
Fig. 4Scatter plot showing relationships between percent increase in stiffness index and age in survivors (solid circles) and controls (empty circles). The solid and dashed black lines represent the slope of percentage change in stiffness index with age in survivors and controls, respectively
Univariate and multivariate analyses of arterial stiffness index and exercise-induced changes
| Baseline stiffness index | Percentage increased in stiffness index during exercise | |||||||
|---|---|---|---|---|---|---|---|---|
| r | p | β | p | r | p | β | p | |
| Age at study | 0.08 | 0.31 | 0.22 | 0.003 | 0.24 | 0.002 | 0.15 | 0.07 |
| Gender | −0.27 | 0.001 | − 0.18 | 0.021 | 0.02 | 0.80 | −0.01 | 0.95 |
| At rest | ||||||||
| SBP | 0.29 | < 0.001 | 0.59 | < 0.001 | −0.08 | 0.31 | −0.06 | 0.47 |
| DBP | −0.07 | 0.36 | −0.53 | < 0.001 | 0.12 | 0.14 | 0.09 | 0.27 |
| cSBP | 0.02 | 0.81 | −0.09 | 0.29 | 0.07 | 0.36 | 0.03 | 0.67 |
| Adjusted rAI | −0.15 | 0.06 | 0.07 | 0.42 | 0.21 | 0.009 | 0.10 | 0.22 |
| Carotid IMT | 0.02 | 0.78 | 0.08 | 0.29 | 0.32 | < 0.001 | 0.32 | < 0.001 |
| At submaximal exercise | ||||||||
| SBP | 0.25 | 0.002 | 0.13 | 0.14 | 0.01 | 0.89 | 0.02 | 0.77 |
| DBP | −0.01 | 0.93 | −0.03 | 0.71 | −0.03 | 0.74 | −0.08 | 0.29 |
Abbreviations as in Table 1 and Table 2
All of the parameters were entered into the multivariate analysis. The correlation coefficient r for univariate analysis and β coefficient for multivariate analysis are presented